- Importance of classifying epilepsy both by syndrome and etiology
- What is new in the guidelines on the clinical management and treatment of the epilepsy syndromes in neonates, infants, and in childhood
- Diagnostic electroclinical criteria
- Expected results of other investigations- imaging and genetics
- Guidance on the criteria for syndrome diagnosis in resource-limited regions where laboratory confirmation, including EEG, MRI and genetic testing, is not available
- Importance of classifying epilepsy both by syndrome and etiology
- What is new in the guidelines on the clinical management and treatment of the epilepsy syndromes with onset at a variable age and in idiopathic generalized epilepsy(IGE) syndrom
- Recent advances in genetics, imaging and EEG studies
- Genetic generalized epilepsies (GGEs)
- Recognition of the IGEs as a distinct subgroup of the GGEs
Epilepsy Syndromes - Updated Classifications and Clinical Management Guidelines
Session 1 - May 25, 2022 / 16:00 CET
Session 2 - May 30, 2022 / 16:00 CET
Epilepsy Syndromes in Neonates, Infants, and with Onset of Childhood
In the first of two webinars hear from the Experts and authors of these papers discuss:
Epilepsy Syndromes with onset at a variable age, and idiopathic generalized epilepsy syndromes
In the second of two webinars hear from the Experts and authors of these papers discuss:
These webinars have been supported by Zogenix International Limited, now a part of UCB. Zogenix International Limited has had no influence over the content or selection of the Editorial Panel.
Jointly Provided by Oakstone Publishing and John Wiley and Sons Limited
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing and John Wiley and Sons Limited, Oakstone Publishing is accredited by the ACCME to provide continuing medical education for physicians.
Oakstone Publishing designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.